A61K35/765 - CPC Classification Index

#1

20240041959

2024-02-08

NOVEL MODIFIED REOVIRUS AND USE THEREOF

#2

20240024393

2024-01-25

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, COMPRISING SQUIRREL FIBROMA VIRUS AND REOVIRUS

#3

20230277633

2023-09-07

PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF

#4

20230241141

2023-08-03

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER

#5

20230165916

2023-06-01

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY DISEASES OF DIGESTIVE SYSTEM OR COLITIS, COMPRISING REOVIRUS AS ACTIVE INGREDIENT

#6

20220339220

2022-10-27

THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS

#7

20220313720

2022-10-06

TARGETED CANCER THERAPY

#8

20220111034

2022-04-14

VIRUS COMPOSITIONS

#9

20220105143

2022-04-07

T CELL REPERTOIRE DYNAMICS AND ONCOLYTIC VIRAL THERAPY

#10

20210008136

2021-01-14

Oncolytic reovirus

#11

20200384103

2020-12-10

SMC COMBINATION THERAPY FOR THE TREATMENT OF CANCER

#12

20200237917

2020-07-30

Reoviruses having modified sequences

#13

20200197457

2020-06-25

Oncolytic virus for expression of immune checkpoint modulators

#14

20200123204

2020-04-23

RECOMBINANT ONCOLYTIC VIRUSES FOR TREATMENT OF METASTATIC CANCERS

#15

20190343881

2019-11-14

THERAPEUTIC AGENTS COMPRISING ONCOLYTIC VACCINIA VIRUSES AND NK CELLS, AND USES THEREOF FOR DRUGS FOR TREATMENT OF TUMORS AND/OR CANCERS

#16

20190336549

2019-11-07

Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers

#17

20190255127

2019-08-22

Augmentation of Oncolytic Viral Efficacy through Immunological Targeting Tumor Endothelial Cells

#18

20190151384

2019-05-23

Medicinal composition for treating fibrosis

#19

20190134228

2019-05-09

System and Method for Managing All Cancers by Disabling the Cancer Cells Ability to Reproduce

#20

20180369302

2018-12-27

Epizootic hemorrhagic disease virus—tel aviv university (EHDV-TAU)—oncolytic virus for treating cancer

#21

20180344853

2018-12-06

Reoviruses having modified sequences

#22

20180311269

2018-11-01

Targeted cancer therapy

#23

20180209978

2018-07-26

UNIVERSAL, NON-INVASIVE, EARLY DETECTION SYSTEM FOR CANCERS

#24

20170239347

2017-08-24

SMC combination therapy for the treatment of cancer

#25

20170049829

2017-02-23

Attenuated reovirus

#26

20160271193

2016-09-22

ONCOLYTIC VIRUSES AND INCREASED CANCER TREATMENT REGIMENS

#27

20150224198

2015-08-13

Lyophilized viral formulations

#28

20150224155

2015-08-13

Liquid viral formulations

#29

20140186301

2014-07-03

Reoviruses having modified sequences

#30

20130243732

2013-09-19

ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY

#31

20130017172

2013-01-17

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#32

20120225045

2012-09-06

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#33

20120141528

2012-06-07

Lyophilized viral formulations

#34

20120141426

2012-06-07

Reovirus for the treatment of cellular proliferative disorders

#35

20120141421

2012-06-07

Liquid viral formulations

#36

20110243890

2011-10-06

Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus

#37

20110086005

2011-04-14

MODULATING INTERSTITIAL PRESSURE AND ONCOLYTIC VIRAL DELIVERY AND DISTRIBUTION

#38

20110070200

2011-03-24

Abrogating proinflammatory cytokine production during oncolytic reovirus therapy

#39

20110020288

2011-01-27

Reoviruses having modified sequences

#40

20110014155

2011-01-20

Reovirus for the treatment of cellular proliferative disorders

#41

20100248205

2010-09-30

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#42

20100247622

2010-09-30

TREATMENT REGIME FOR PROLIFERATIVE DISORDERS

#43

20100021432

2010-01-28

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#44

20090280122

2009-11-12

USE OF A VIRUS REGIMEN FOR THE TREATMENT OF DISEASES

#45

20090214479

2009-08-27

Attenuated reovirus

#46

20090117082

2009-05-07

Reovirus for the treatment of cellular proliferative disorders

#47

20090110665

2009-04-30

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

#48

20090104162

2009-04-23

Attenuated reoviruses for selection of cell populations

#49

20090098089

2009-04-16

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

#50

20090053186

2009-02-26

Therapy for primary and metastatic cancers

#51

20090035278

2009-02-05

REOVIRUSES HAVING MODIFIED SEQUENCES

#52

20080226602

2008-09-18

Reoviruses having modified sequences

#53

20080081032

2008-04-03

Method for reducing pain using oncolytic viruses

#54

20080075729

2008-03-27

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#55

20080057073

2008-03-06

Methods for the treatment of cellular proliferative disorders

#56

20080038822

2008-02-14

Virus clearance of neoplastic cells from mixed cellular compositions

#57

20080032279

2008-02-07

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#58

20080031851

2008-02-07

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#59

20080026048

2008-01-31

Reovirus for the treatment of cellular proliferative disorders

#60

20070280952

2007-12-06

Modified reoviral therapy

#61

20070190032

2007-08-16

Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy

#62

20070141033

2007-06-21

PURGING OF CELLS USING VIRUSES

#63

20070071723

2007-03-29

In Vivo Enhancement of Immune System Recognition of Neoplasms Following Treatment with an Oncolytic Virus or Gene Therapy Vector

#64

20060172288

2006-08-03

Methods for the treatment of cellular proliferative disorders

#65

20060165724

2006-07-27

Method of producing infectious reovirus

#66

20060073166

2006-04-06

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#67

20060029598

2006-02-09

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#68

20050214266

2005-09-29

Combination of transplantation and oncolytic virus treatment

#69

20050137152

2005-06-23

Reovirus for the prevention of neoplasia

#70

20050123513

2005-06-09

Reovirus for the treatment of neoplasia

#71

20050095692

2005-05-05

Method of extracting virus from cell culture

#72

20050063954

2005-03-24

Reovirus for the treatment of cellular proliferative disorders

#73

20050031594

2005-02-10

Pharmaceutical composition for treatment of cancers

#74

20050026289

2005-02-03

Virus clearance of neoplastic cells from mixed cellular compositions

#75

20050019308

2005-01-27

Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac